Search

everythinglearnresearchcommunity

for

Search:↓

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Mogamulizumab can cause hair loss and skin rashes.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The document explains various skin conditions and their treatments.

Somatostatin may help protect hair follicles from immune attacks.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Iron deficiency might contribute to hair loss in women.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.